中文名稱

英文名稱

CAS號(hào)

厄洛替尼標(biāo)準(zhǔn)品

Erlotinib

183321-74-6

鹽酸厄洛替尼標(biāo)準(zhǔn)品

Tarceva (Erlotinib Hydrochloride)

183319-69-9

去甲厄洛替尼羧酸鹽酸

DesMethyl Erlotinib Carboxylate Acid

1170354-84-3

去甲基乙酰厄洛替尼

Desmethyl Erlotinib Acetate

183320-15-2

厄洛替尼雜質(zhì)1

Desmethyl Erlotinib

183321-86-0

厄洛替尼雜質(zhì)2

Didesmethyl Erlotinib

183320-12-9

厄洛替尼雜質(zhì)3

Erlotinib Carboxylic Acid

厄洛替尼羥基代謝物

Erlotinib Hydroxy Metabolite

厄洛替尼雜質(zhì)4

3-Ethynylailine

54060-30-9

厄洛替尼雜質(zhì)5

3-Ethynylaniline-d4

厄洛替尼雜質(zhì)6

4-Chloro-6-(2-Chloroethoxy)-7-(2-Methoxyethoxy)-Quinazoline

183322-19-2

厄洛替尼雜質(zhì)7

4-Chloro-7-(2-Chloroethoxy)-6-(2-Methoxyethoxy)-Quinazoline

183322-20-5

厄洛替尼雜質(zhì)8

6,7-bis(2-chloroethoxy)

183321-82-6

厄洛替尼雜質(zhì)9

6-(2-chloroethoxy)-7-(2-methoxyethoxy)

183321-85-9

厄洛替尼雜質(zhì)10

6-(2-methoxyethoxy)-7-(2-chloroethoxy)

183321-83-7

厄洛替尼代謝物M11

Erlotinib Metabolite M11(Desmethyl Erlotinib Carboxylate Acid)

882172-60-3

厄洛替尼O-去甲代謝物異構(gòu)體(M13)

Erlotinib O-DesMethyl Metabolite IsoMer (M13)

厄洛替尼雜質(zhì)11

Erlotinib O-Desmethyl Metabolite Isomer (M14) HCl

183320-51-6

厄洛替尼雜質(zhì)12

Erlotinib-d6 HCl

1189953-78-3

厄洛替尼雜質(zhì)13

Ethyl 4,5-Bis(2-methoxyethoxy)-2-nitrobenzoate

179688-26-7

厄洛替尼雜質(zhì)14

6,7-bis(2-Methoxyethoxy)-3,4-dihydroquinazolin-4-one

179688-29-0

厄洛替尼雜質(zhì)15

4-Methyl Erlotinib Hydrochloride

厄洛替尼雜質(zhì)16

Desmethyl Erlotinib-d4

厄洛替尼雜質(zhì)17

4-Chloro-6,7-bis-(2-chloroethoxy)quinazoline

 183322-21-6

厄洛替尼雜質(zhì)18

6-O-Desmethoxyethyl-6-O-chloroethyl Erlotinib Hydrochloride

183320-04-9

厄洛替尼雜質(zhì)19

7-O-Desmethoxy-7-O-chloroethyl Erlotinib Hydrochloride

183320-19-6

厄洛替尼雜質(zhì)20

N-(3-Desethynylphenyl)-N-(3-bromophenyl) Erlotinib Hydrochloride-D6

厄洛替尼雜質(zhì)21

N-(3-Desethynylphenyl)-N-(3-bromophenyl) Erlotinib

328528-74-1

95/647

Interleukin-108 (Human, rDNA derived)

01/524

Meningococcal serogroup W polysaccharide

12/B623-042

QCRFLUAH1N1QC1-Influenza AH1N1 QC40

03/104-090

HTLV-75 (antibody) Monitor Sample

10/174

Reteplase Reference Material

03/104-089

HTLV-74 (antibody) Monitor Sample

01/458

Meningococcal serogroup W polysaccharide

13/197

Influenza Antigen B/Massachusetts/02/2075 (Egg derived)

07/374

BCG Vaccine of Russian BCG-I sub-strain(101st WHO Reference Reagent)

07/376

BCG Vaccine of Russian BCG-I sub-strain(103st WHO Reference Reagent)

13/280

Polio Anti Sabin type 63 (inactivated) Serum

95/575

Interleukin-36 (Human, rDNA derived)

10/166

Reteplase Reference Material

13/141

Influenza Antigen B/Massachusetts/02/2019 (Egg derived)

95/634

Interleukin-95 (Human, rDNA derived)

95/633

Interleukin-94 (Human, rDNA derived)

95/568

Interleukin-29 (Human, rDNA derived)

10/194

Reteplase Reference Material

07/340

BCG Vaccine of Russian BCG-I sub-strain(67st WHO Reference Reagent)

13/164

C-Peptide, Human. 19st International Standard.

13/198

C-Peptide, Human. 53st International Standard.

03/104-065

HTLV-50 (antibody) Monitor Sample

13/170

Influenza Antigen B/Massachusetts/02/2048 (Egg derived)

13/206

Influenza Antigen B/Massachusetts/02/2084 (Egg derived)

07/336

BCG Vaccine of Russian BCG-I sub-strain(63st WHO Reference Reagent)